Le Lézard
Classified in: Business, Covid-19 virus
Subjects: EARNINGS, Conference Call, Webcast

RenaissanceRe Reports Q1 2022 Net Loss Attributable to Common Shareholders of $394.4 Million; Operating Income Available to Common Shareholders of $151.9 Million. Poised to Deliver Shareholder Value Across Underwriting, Fees and Investments.


RenaissanceRe Holdings Ltd. (NYSE: RNR) ("RenaissanceRe" or the "Company") today announced its financial results for the first quarter of 2022.

Net Loss Attributable to Common Shareholders per Diluted Common Share: $(9.10)

Operating Income Available to Common Shareholders per Diluted Common Share*: $3.50

Underwriting Income

$200.3M

Fee Income

$28.3M

Net Investment Income

$83.7M

Change in Book Value per Common Share: (8.1)%

Change in Tangible Book Value per Common Share Plus Change in Accum. Dividends*: (8.2)%

*

Operating Return on Average Common Equity, Operating Income (Loss) Available (Attributable) to Common Shareholders, Operating Income (Loss) Available (Attributable) to Common Shareholders per Diluted Common Share and Change in Tangible Book Value per Common Share Plus Change in Accumulated Dividends are non-GAAP financial measures; see "Comments on Regulation G" for a reconciliation of non-GAAP financial measures.

Kevin J. O'Donnell, President and Chief Executive Officer, said, "We would like to recognize the great human tragedy of the ongoing Russia-Ukraine War and hope for rapid cessation of hostilities and peace in the region. There were also numerous natural catastrophes this quarter and we would like to extend our sympathies to all those impacted. Our purpose is to protect communities and enable prosperity and these events reinforce the importance of our role in helping our stakeholders manage many different forms of volatility.

 

For our shareholders, we delivered a solid double digit operating return while generating profits in both underwriting segments. Our balance sheet is strong and all three of our drivers of profit should benefit from improving market conditions: our underwriting from material rate increases across most lines as well as continuing growth in our Casualty and Specialty segment; our fee income business from the launch of our groundbreaking Casualty and Specialty joint venture Fontana; and our investment income from rising interest rates. We believe that all of these factors will make our financial results increasingly resilient to natural catastrophe volatility and produce superior returns for our shareholders."

Consolidated Financial Results

 

Consolidated Highlights

 

 

 

 

 

Three months ended
March 31

 

(in thousands, except per share amounts and percentages)

2022

 

2021

 

Gross premiums written

$

2,942,964

 

 

$

2,652,442

 

 

Net premiums written

 

2,165,217

 

 

 

1,824,083

 

 

Underwriting income (loss)

 

200,278

 

 

 

(35,760

)

 

Combined ratio

 

86.5

%

 

 

103.1

%

 

 

 

 

 

 

Net Income (Loss)

 

 

 

 

Available (Attributable) to common shareholders

 

(394,413

)

 

 

(290,934

)

 

Available (Attributable) to common shareholders per diluted common share

$

(9.10

)

 

$

(5.87

)

 

Operating Income (Loss) (1)

 

 

 

 

Available (Attributable) to common shareholders

 

151,945

 

 

 

4,395

 

 

Available (Attributable) to common shareholders per diluted common share

$

3.50

 

 

$

0.09

 

 

Book value per common share

$

121.44

 

 

$

131.15

 

 

Change in book value per share

 

(8.1

) %

 

 

(5.3

) %

 

Tangible book value per common share plus accumulated dividends (1)

$

139.44

 

 

$

148.17

 

 

Change in tangible book value per common share plus change in accumulated dividends (1)

 

(8.2

) %

 

 

(5.3

) %

 

 

 

 

 

 

Return on average common equity - annualized

 

(28.1

) %

 

 

(17.1

) %

 

Operating return on average common equity - annualized (1)

 

10.8

%

 

 

0.3

%

(1)

See "Comments on Regulation G" for a reconciliation of non-GAAP financial measures.

Net Negative Impact

Net negative impact on underwriting result includes the sum of (1) net claims and claim expenses incurred, (2) assumed and ceded reinstatement premiums earned and (3) earned and lost profit commissions. Net negative impact on net income (loss) available (attributable) to RenaissanceRe common shareholders is the sum of (1) net negative impact on underwriting result and (2) redeemable noncontrolling interest, both before consideration of any related income tax benefit (expense).

Estimates of net negative impact are based on a review of potential exposures, preliminary discussions with certain counterparties and actuarial modeling techniques. Actual net negative impact, both individually and in the aggregate, may vary from these estimates, perhaps materially. Changes in these estimates will be recorded in the period in which they occur.

Meaningful uncertainty remains regarding the estimates and the nature and extent of losses from catastrophe events, driven by the magnitude and recent nature of each event, the geographic areas impacted by the events, relatively limited claims data received to date, the contingent nature of business interruption and other exposures, potential uncertainties relating to reinsurance recoveries, and other factors inherent in loss estimation, among other things.

In February 2022, Russia launched an invasion into Ukraine. There is uncertainty associated with the scale, duration and impact of this situation, which we continue to actively monitor. The Company's loss estimates represent its best estimate of incurred losses based on currently available information, and actual losses may vary materially from these estimates.

Weather-Related Large Losses

Net negative impact on the consolidated financial statements

 

 

 

 

 

 

Three months ended March 31, 2022

 

Q1 2022
Weather-
Related Large
Losses (1)

 

 

(in thousands)

 

 

 

 

Net claims and claims expenses incurred

 

$

(112,933

)

 

 

Assumed reinstatement premiums earned

 

 

10,967

 

 

 

Ceded reinstatement premiums earned

 

 

(299

)

 

 

Earned (lost) profit commissions

 

 

?

 

 

 

Net negative impact on underwriting result

 

 

(102,265

)

 

 

Redeemable noncontrolling interest

 

 

34,347

 

 

 

Net negative impact on net income (loss) available (attributable) to RenaissanceRe common shareholders

 

$

(67,918

)

 

 

 

 

 

 

Net negative impact on the segment underwriting results and consolidated combined ratio

 

 

 

 

 

 

Three months ended March 31, 2022

 

Q1 2022
Weather-
Related Large
Losses (1)

 

 

(in thousands, except percentages)

 

 

 

 

Net negative impact on Property segment underwriting result

 

$

(102,265

)

 

 

Net negative impact on Casualty and Specialty segment underwriting result

 

 

?

 

 

 

Net negative impact on underwriting result

 

$

(102,265

)

 

 

Percentage point impact on consolidated combined ratio

 

 

7.0

 

 

 

 

 

 

 

(1)

"Q1 2022 Weather-Related Large Losses" includes the Australian Floods which impacted Eastern Australia in February and March 2022, and Storm Eunice which impacted several areas in Europe in February 2022.

Russia-Ukraine War Losses

In the first quarter of 2022, losses related to Russia's invasion of Ukraine resulted in a net negative impact on net income (loss) available (attributable) to RenaissanceRe common shareholders of $24.9 million. This reflects net claims and claims expenses incurred and net negative impact on underwriting result of $27.1 million, solely in the Casualty and Specialty segment, partially offset by redeemable noncontrolling interest of $2.2 million. The net negative impact on underwriting result had a 1.8 percentage point impact on the consolidated combined ratio.

Three Drivers of Profit: Underwriting, Fee and Investment Income

Underwriting Results - Property Segment: Combined ratio of 70.1%; 17.3 percentage points from the Q1 2022 Weather-Related Large Losses

 

Property Segment

 

 

 

 

 

 

 

Three months ended
March 31

 

Q/Q
Change

 

(in thousands, except percentages)

2022

 

2021

 

 

Gross premiums written

$

1,343,508

 

 

$

1,616,819

 

 

(16.9

) %

 

Net premiums written

 

890,166

 

 

 

1,008,460

 

 

(11.7

) %

 

Underwriting income (loss)

 

184,802

 

 

 

(41,795

)

 

 

 

 

 

 

 

 

 

 

Underwriting Ratios

 

 

 

 

 

 

Net claims and claim expense ratio - current accident year

 

44.7

%

 

 

83.3

%

 

(38.6) pts

 

Net claims and claim expense ratio - prior accident years

 

(2.7

) %

 

 

(0.9

) %

 

(1.8) pts

 

Net claims and claim expense ratio - calendar year

 

42.0

%

 

 

82.4

%

 

(40.4) pts

 

Underwriting expense ratio

 

28.1

%

 

 

24.5

%

 

3.6 pts

 

Combined ratio

 

70.1

%

 

 

106.9

%

 

(36.8) pts

? $175.5 million reduction in Upsilon RFO Re Ltd. ("Upsilon RFO").

? $79.1 million reduction in assumed reinstatement premiums due to lower impact from the Q1 2022 Weather-Related Large Losses, as compared to Winter Storm Uri in the first quarter of 2021.

? $28.3 million decrease in the other property class of business, principally due to the planned non-renewal of certain deals, which is partially offset by growth and rate improvement across other areas of business.

Underwriting Results - Casualty and Specialty Segment: Grew net premiums written by 56.3% and reported a combined ratio of 98.2%

 

Casualty and Specialty Segment

 

 

 

 

 

 

 

Three months ended
March 31

 

Q/Q
Change

 

(in thousands, except percentages)

2022

 

2021

 

 

Gross premiums written

$

1,599,456

 

 

$

1,035,623

 

 

54.4

%

 

Net premiums written

 

1,275,051

 

 

 

815,623

 

 

56.3

%

 

Underwriting income (loss)

 

15,476

 

 

 

6,035

 

 

 

 

 

 

 

 

 

 

 

Underwriting Ratios

 

 

 

 

 

 

Net claims and claim expense ratio - current accident year

 

67.2

%

 

 

67.8

%

 

(0.6) pts

 

Net claims and claim expense ratio - prior accident years

 

(0.1

) %

 

 

(0.7

) %

 

0.6 pts

 

Net claims and claim expense ratio - calendar year

 

67.1

%

 

 

67.1

%

 

? pts

 

Underwriting expense ratio

 

31.1

%

 

 

31.8

%

 

(0.7) pts

 

Combined ratio

 

98.2

%

 

 

98.9

%

 

(0.7) pts

Fee Income: $28.3 million of fee income; performance fees impacted by deficit carried forward from weather-related losses in 2021

 

Fee Income

 

 

 

 

 

 

 

Three months ended
March 31

 

Q/Q
Change

 

(in thousands, except percentages)

2022

 

2021

 

 

Total management fee income

$

27,222

 

$

28,524

 

 

$

(1,302

)

 

Total performance fee income (loss) (1)

 

1,127

 

 

(4,535

)

 

 

5,662

 

 

Total fee income

$

28,349

 

$

23,989

 

 

$

4,360

 

(1)

Performance fees are based on the performance of the individual vehicles or products, and may be negative in a particular period if, for example, large losses occur, which can potentially result in no performance fees or the reversal of previously accrued performance fees.

? Performance fee income was higher in the first quarter of 2022, however, continued to be negatively impacted by the underwriting deficit carried forward from the weather-related losses in 2021; the performance fee income in the first quarter of 2021 was negatively impacted by the impact of Winter Storm Uri losses.

? Management fee income was lower in the first quarter of 2022, primarily due to the reduced size of the Company's structured reinsurance products and lower capital managed at Upsilon, partially offset by increased capital managed at other joint ventures and managed funds.

Investment Results: Performance primarily driven by net realized and unrealized losses in the fixed maturity investments portfolio

 

Investment Results

 

 

 

 

 

 

 

Three months ended
March 31

 

Q/Q
Change

 

(in thousands, except percentages)

2022

 

2021

 

 

Net investment income

$

83,691

 

 

$

79,804

 

 

$

3,887

 

 

Net realized and unrealized gains (losses) on investments

 

(673,017

)

 

 

(345,563

)

 

 

(327,454

)

 

Total investment result

 

(589,326

)

 

 

(265,759

)

 

 

(323,567

)

 

Total investment return - annualized

 

(10.2

) %

 

 

(4.9

) %

 

(5.3) pts

? In the first quarter of 2022, net realized and unrealized losses on fixed maturity investments of $618.3 million were primarily driven by unrealized mark-to-market losses resulting from the significant increase in interest rates. In addition, net realized and unrealized losses of $56.1 million on equity investments were in line with the wider equity markets.

? In the first quarter of 2021, net realized and unrealized losses on fixed maturity investments of $261.8 million were largely driven by increasing interest rates. In addition, net realized and unrealized losses of $67.9 million on equity investments were primarily driven by losses in the Company's strategic investment portfolio.

Other Items of Note

? DaVinciRe Holdings Ltd. ("DaVinciRe"), which had a net loss in the first quarter of 2022 due to realized and unrealized losses on investments, driven by the increase in interest rates discussed previously, as compared to a larger net loss in the first quarter of 2021, which was driven by losses from Winter Storm Uri; and

? RenaissanceRe Medici Fund Ltd. ("Medici"), which, while generating positive returns for Medici's investors, had a net loss attributable to redeemable noncontrolling interests in the first quarter of 2022 due to foreign exchange losses on hedges related to foreign currency share classes held by third-party investors. After taking into account the original currency carrying value of Medici's foreign currency share classes, foreign currency hedges had no net impact to Medici's investors. This was partially offset by

? Vermeer Reinsurance Ltd. ("Vermeer"), which had improved net income in the first quarter of 2022 as compared to the first quarter of 2021, which was impacted by losses from Winter Storm Uri.

? Launched Fontana Holdings L.P. and its subsidiaries ("Fontana") with capital commitments of $475.0 million. In April 2022, $400.0 million of this amount had been funded, comprised of $273.7 million from third-party investors and $126.3 million from the Company; and

? Raised an additional $147.0 million through Medici, including $10.0 million from the Company.

Conference Call Details and Additional Information

Non-GAAP Financial Measures and Additional Financial Information

This Press Release includes certain financial measures that are not calculated in accordance with generally accepted accounting principles in the U.S. ("GAAP") including "operating Income (loss) available (attributable) to RenaissanceRe common shareholders," "operating Income (loss) available (attributable) to RenaissanceRe common shareholders per common share - diluted," "operating return on average common equity - annualized," "tangible book value per common share" and "tangible book value per common share plus accumulated dividends." A reconciliation of such measures to the most comparable GAAP figures in accordance with Regulation G is presented in the attached supplemental financial data.

Please refer to the "Investors - Financial Reports - Financial Supplements" section of the Company's website at www.renre.com for a copy of the Financial Supplement which includes additional information on the Company's financial performance.

Conference Call Information

RenaissanceRe will host a conference call on Wednesday, May 4, 2022 at 11:00 a.m. ET to discuss this release. Live broadcast of the conference call will be available through the "Investors - Webcasts & Presentations" section of the Company's website at www.renre.com.

About RenaissanceRe

RenaissanceRe is a global provider of reinsurance and insurance that specializes in matching well-structured risks with efficient sources of capital. The Company provides property, casualty and specialty reinsurance and certain insurance solutions to customers, principally through intermediaries. Established in 1993, RenaissanceRe has offices in Bermuda, Australia, Ireland, Singapore, Switzerland, the United Kingdom and the United States.

Cautionary Statement Regarding Forward-Looking Statements

Any forward-looking statements made in this Press Release reflect RenaissanceRe's current views with respect to future events and financial performance and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements are subject to numerous factors that could cause actual results to differ materially from those set forth in or implied by such forward-looking statements, including the following: the Company's exposure to natural and non-natural catastrophic events and circumstances and the variance it may cause in the Company's financial results; the effect of climate change on the Company's business, including the trend towards increasingly frequent and severe climate events; the effectiveness of the Company's claims and claim expense reserving process; the effect of emerging claims and coverage issues; the highly competitive nature of the Company's industry, resulting in consolidation of competitors, customers and (re)insurance brokers, and the Company's reliance on a small and decreasing number of brokers; the historically cyclical nature of the (re)insurance industries; collection on claimed retrocessional coverage, and new retrocessional reinsurance being available on acceptable terms; the ability of the Company's ceding companies and delegated authority counterparties to accurately assess the risks they underwrite; the Company's ability to maintain its financial strength ratings; the impact of large non-recurring contracts and reinstatement premiums on the Company's financial results; the Company's ability to attract and retain key executives and employees; the effect of cybersecurity risks, including technology breaches or failure; the performance of the Company's investment portfolio and financial market volatility; the effects of inflation; the Company's ability to successfully implement its business strategies and initiatives, and the success of any of the Company's strategic investments or acquisitions, including its ability to manage its operations as its product and geographical diversity increases; the Company's exposure to credit loss from counterparties; the Company's need to make many estimates and judgments in the preparation of its financial statements; the Company's ability to effectively manage capital on behalf of investors in joint ventures or other entities it manages; changes to the accounting rules and regulatory systems applicable to the Company's business, including changes in Bermuda laws or regulations or as a result of increased global regulation of the insurance and reinsurance industries; other political, regulatory or industry initiatives adversely impacting the Company; the Company's ability to comply with covenants in its debt agreements; a contention by the U.S. Internal Revenue Service that any of the Company's Bermuda subsidiaries are subject to taxation in the U.S.; the effects of possible future tax reform legislation and regulations, including changes to the tax treatment of the Company's shareholders or investors in its joint ventures or other entities it manages; the Company's ability to determine any impairments taken on its investments; the uncertainty of the continuing and future impact of the COVID-19 pandemic, including measures taken in response thereto and the effect of legislative, regulatory and judicial influences on the Company's potential reinsurance, insurance and investment exposures, or other effects that it may have; foreign currency exchange rate fluctuations; the Company's ability to raise capital if necessary; the Company's ability to comply with applicable sanctions and foreign corrupt practices laws; the Company's dependence on the ability of its operating subsidiaries to declare and pay dividends; aspects of the Company's corporate structure that may discourage third-party takeovers and other transactions; difficulties investors may have in serving process or enforcing judgments against the Company in the U.S.; and other factors affecting future results disclosed in RenaissanceRe's filings with the SEC, including its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q.

RenaissanceRe Holdings Ltd.

Summary Consolidated Statements of Operations

(in thousands of United States Dollars, except per share amounts and percentages)

(Unaudited)

 

Three months ended

 

March 31,
2022

 

March 31,
2021

Revenues

 

 

 

Gross premiums written

$

2,942,964

 

 

$

2,652,442

 

Net premiums written

$

2,165,217

 

 

$

1,824,083

 

Decrease (increase) in unearned premiums

 

(678,792

)

 

 

(670,247

)

Net premiums earned

 

1,486,425

 

 

 

1,153,836

 

Net investment income

 

83,691

 

 

 

79,804

 

Net foreign exchange gains (losses)

 

(15,486

)

 

 

(22,788

)

Equity in earnings (losses) of other ventures

 

(6,390

)

 

 

(5,558

)

Other income (loss)

 

1,193

 

 

 

2,171

 

Net realized and unrealized gains (losses) on investments

 

(673,017

)

 

 

(345,563

)

Total revenues

 

876,416

 

 

 

861,902

 

Expenses

 

 

 

Net claims and claim expenses incurred

 

841,733

 

 

 

867,051

 

Acquisition expenses

 

376,507

 

 

 

267,234

 

Operational expenses

 

67,907

 

 

 

55,311

 

Corporate expenses

 

12,502

 

 

 

10,405

 

Interest expense

 

11,955

 

 

 

11,912

 

Total expenses

 

1,310,604

 

 

 

1,211,913

 

Income (loss) before taxes

 

(434,188

)

 

 

(350,011

)

Income tax benefit (expense)

 

36,707

 

 

 

19,516

 

Net income (loss)

 

(397,481

)

 

 

(330,495

)

Net (income) loss attributable to redeemable noncontrolling interests

 

11,912

 

 

 

46,850

 

Net income (loss) attributable to RenaissanceRe

 

(385,569

)

 

 

(283,645

)

Dividends on preference shares

 

(8,844

)

 

 

(7,289

)

Net income (loss) available (attributable) to RenaissanceRe common shareholders

$

(394,413

)

 

$

(290,934

)

 

 

 

 

Net income (loss) available (attributable) to RenaissanceRe common shareholders per common share ? basic

$

(9.10

)

 

$

(5.87

)

Net income (loss) available (attributable) to RenaissanceRe common shareholders per common share ? diluted

$

(9.10

)

 

$

(5.87

)

Operating (loss) income (attributable) available to RenaissanceRe common shareholders per common share - diluted (1)

$

3.50

 

 

$

0.09

 

 

 

 

 

Average shares outstanding - basic

 

43,357

 

 

 

49,579

 

Average shares outstanding - diluted

 

43,357

 

 

 

49,579

 

 

 

 

 

Net claims and claim expense ratio

 

56.6

%

 

 

75.1

%

Underwriting expense ratio

 

29.9

%

 

 

28.0

%

Combined ratio

 

86.5

%

 

 

103.1

%

 

 

 

 

Return on average common equity - annualized

 

(28.1

) %

 

 

(17.1

) %

Operating return on average common equity - annualized (1)

 

10.8

%

 

 

0.3

%

(1)

See Comments on Regulation G for a reconciliation of non-GAAP financial measures.

RenaissanceRe Holdings Ltd.

Summary Consolidated Balance Sheets

(in thousands of United States Dollars, except per share amounts)

 

 

 

 

 

March 31,
2022

 

December 31,
2021

Assets

(Unaudited)

 

(Audited)

Fixed maturity investments trading, at fair value

$

13,029,085

 

 

$

13,507,131

 

Short term investments, at fair value

 

4,685,280

 

 

 

5,298,385

 

Equity investments trading, at fair value

 

873,268

 

 

 

546,016

 

Other investments, at fair value

 

2,182,479

 

 

 

1,993,059

 

Investments in other ventures, under equity method

 

81,106

 

 

 

98,068

 

Total investments

 

20,851,218

 

 

 

21,442,659

 

Cash and cash equivalents

 

1,563,056

 

 

 

1,859,019

 

Premiums receivable

 

4,851,513

 

 

 

3,781,542

 

Prepaid reinsurance premiums

 

1,185,982

 

 

 

854,722

 

Reinsurance recoverable

 

4,319,490

 

 

 

4,268,669

 

Accrued investment income

 

60,802

 

 

 

55,740

 

Deferred acquisition costs and value of business acquired

 

999,712

 

 

 

849,160

 

Receivable for investments sold

 

486,705

 

 

 

380,442

 

Other assets

 

287,485

 

 

 

224,053

 

Goodwill and other intangible assets

 

242,116

 

 

 

243,496

 

Total assets

$

34,848,079

 

 

$

33,959,502

 

Liabilities, Noncontrolling Interests and Shareholders' Equity

 

 

 

Liabilities

 

 

 

Reserve for claims and claim expenses

$

13,510,304

 

 

$

13,294,630

 

Unearned premiums

 

4,546,305

 

 

 

3,531,213

 

Debt

 

1,168,872

 

 

 

1,168,353

 

Reinsurance balances payable

 

4,319,657

 

 

 

3,860,963

 

Payable for investments purchased

 

907,945

 

 

 

1,170,568

 

Other liabilities

 

314,141

 

 

 

755,441

 

Total liabilities

 

24,767,224

 

 

 

23,781,168

 

Redeemable noncontrolling interests

 

3,963,895

 

 

 

3,554,053

 

Shareholders' Equity

 

 

 

Preference shares

 

750,000

 

 

 

750,000

 

Common shares

 

44,193

 

 

 

44,445

 

Additional paid-in capital

 

513,631

 

 

 

608,121

 

Accumulated other comprehensive income (loss)

 

(12,834

)

 

 

(10,909

)

Retained earnings

 

4,821,970

 

 

 

5,232,624

 

Total shareholders' equity attributable to RenaissanceRe

 

6,116,960

 

 

 

6,624,281

 

Total liabilities, noncontrolling interests and shareholders' equity

$

34,848,079

 

 

$

33,959,502

 

 

 

 

 

Book value per common share

$

121.44

 

 

$

132.17

 

RenaissanceRe Holdings Ltd.

Supplemental Financial Data - Segment Information

(in thousands of United States Dollars, except percentages)

(Unaudited)

 

Three months ended March 31, 2022

 

Property

 

Casualty and Specialty

 

Other

 

Total

Gross premiums written

$

1,343,508

 

 

$

1,599,456

 

 

$

?

 

 

$

2,942,964

 

Net premiums written

$

890,166

 

 

$

1,275,051

 

 

$

?

 

 

$

2,165,217

 

Net premiums earned

$

618,591

 

 

$

867,834

 

 

$

?

 

 

$

1,486,425

 

Net claims and claim expenses incurred

 

259,761

 

 

 

581,972

 

 

 

?

 

 

 

841,733

 

Acquisition expenses

 

127,096

 

 

 

249,411

 

 

 

?

 

 

 

376,507

 

Operational expenses

 

46,932

 

 

 

20,975

 

 

 

?

 

 

 

67,907

 

Underwriting income (loss)

$

184,802

 

 

$

15,476

 

 

$

?

 

 

 

200,278

 

Net investment income

 

 

 

 

 

83,691

 

 

 

83,691

 

Net foreign exchange gains (losses)

 

 

 

 

 

(15,486

)

 

 

(15,486

)

Equity in earnings of other ventures

 

 

 

 

 

(6,390

)

 

 

(6,390

)

Other income (loss)

 

 

 

 

 

1,193

 

 

 

1,193

 

Net realized and unrealized gains (losses) on investments

 

 

 

 

 

(673,017

)

 

 

(673,017

)

Corporate expenses

 

 

 

 

 

(12,502

)

 

 

(12,502

)

Interest expense

 

 

 

 

 

(11,955

)

 

 

(11,955

)

Income (loss) before taxes and redeemable noncontrolling interests

 

 

 

 

 

 

 

(434,188

)

Income tax benefit (expense)

 

 

 

 

 

36,707

 

 

 

36,707

 

Net (income) loss attributable to redeemable noncontrolling interests

 

 

 

 

 

11,912

 

 

 

11,912

 

Dividends on preference shares

 

 

 

 

 

(8,844

)

 

 

(8,844

)

Net income (loss) available (attributable) to RenaissanceRe common shareholders

 

 

 

 

 

 

$

(394,413

)

 

 

 

 

 

 

 

 

Net claims and claim expenses incurred ? current accident year

$

276,519

 

 

$

583,047

 

 

$

?

 

 

$

859,566

 

Net claims and claim expenses incurred ? prior accident years

 

(16,758

)

 

 

(1,075

)

 

 

?

 

 

 

(17,833

)

Net claims and claim expenses incurred ? total

$

259,761

 

 

$

581,972

 

 

$

?

 

 

$

841,733

 

 

 

 

 

 

 

 

 

Net claims and claim expense ratio ? current accident year

 

44.7

%

 

 

67.2

%

 

 

 

 

57.8

%

Net claims and claim expense ratio ? prior accident years

 

(2.7

) %

 

 

(0.1

) %

 

 

 

 

(1.2

) %

Net claims and claim expense ratio ? calendar year

 

42.0

%

 

 

67.1

%

 

 

 

 

56.6

%

Underwriting expense ratio

 

28.1

%

 

 

31.1

%

 

 

 

 

29.9

%

Combined ratio

 

70.1

%

 

 

98.2

%

 

 

 

 

86.5

%

 

 

 

 

 

 

 

 

 

Three months ended March 31, 2021

 

Property

 

Casualty and Specialty

 

Other

 

Total

Gross premiums written

$

1,616,819

 

 

$

1,035,623

 

 

$

?

 

 

$

2,652,442

 

Net premiums written

$

1,008,460

 

 

$

815,623

 

 

$

?

 

 

$

1,824,083

 

Net premiums earned

$

605,166

 

 

$

548,670

 

 

$

?

 

 

$

1,153,836

 

Net claims and claim expenses incurred

 

498,832

 

 

 

368,219

 

 

 

?

 

 

 

867,051

 

Acquisition expenses

 

112,754

 

 

 

154,480

 

 

 

?

 

 

 

267,234

 

Operational expenses

 

35,375

 

 

 

19,936

 

 

 

?

 

 

 

55,311

 

Underwriting income (loss)

$

(41,795

)

 

$

6,035

 

 

$

?

 

 

 

(35,760

)

Net investment income

 

 

 

 

 

79,804

 

 

 

79,804

 

Net foreign exchange gains (losses)

 

 

 

 

 

(22,788

)

 

 

(22,788

)

Equity in earnings of other ventures

 

 

 

 

 

(5,558

)

 

 

(5,558

)

Other income (loss)

 

 

 

 

 

2,171

 

 

 

2,171

 

Net realized and unrealized gains (losses) on investments

 

 

 

 

 

(345,563

)

 

 

(345,563

)

Corporate expenses

 

 

 

 

 

(10,405

)

 

 

(10,405

)

Interest expense

 

 

 

 

 

(11,912

)

 

 

(11,912

)

Income (loss) before taxes and redeemable noncontrolling interests

 

 

 

 

 

 

 

(350,011

)

Income tax benefit (expense)

 

 

 

 

 

19,516

 

 

 

19,516

 

Net (income) loss attributable to redeemable noncontrolling interests

 

 

 

 

 

46,850

 

 

 

46,850

 

Dividends on preference shares

 

 

 

 

 

(7,289

)

 

 

(7,289

)

Net income (loss) available (attributable) to RenaissanceRe common shareholders

 

 

 

 

 

 

$

(290,934

)

 

 

 

 

 

 

 

 

Net claims and claim expenses incurred ? current accident year

$

503,994

 

 

$

372,089

 

 

$

?

 

 

$

876,083

 

Net claims and claim expenses incurred ? prior accident years

 

(5,162

)

 

 

(3,870

)

 

 

?

 

 

 

(9,032

)

Net claims and claim expenses incurred ? total

$

498,832

 

 

$

368,219

 

 

$

?

 

 

$

867,051

 

 

 

 

 

 

 

 

 

Net claims and claim expense ratio ? current accident year

 

83.3

%

 

 

67.8

%

 

 

 

 

75.9

%

Net claims and claim expense ratio ? prior accident years

 

(0.9

) %

 

 

(0.7

) %

 

 

 

 

(0.8

) %

Net claims and claim expense ratio ? calendar year

 

82.4

%

 

 

67.1

%

 

 

 

 

75.1

%

Underwriting expense ratio

 

24.5

%

 

 

31.8

%

 

 

 

 

28.0

%

Combined ratio

 

106.9

%

 

 

98.9

%

 

 

 

 

103.1

%

RenaissanceRe Holdings Ltd.

Supplemental Financial Data - Gross Premiums Written

(in thousands of United States Dollars)

(Unaudited)

 

 

 

Three months ended

 

March 31,
2022

 

March 31,
2021

Property Segment

 

 

 

Catastrophe

$

886,091

 

$

1,131,125

Other property

 

457,417

 

 

485,694

Property segment gross premiums written

$

1,343,508

 

$

1,616,819

 

 

 

 

Casualty and Specialty Segment

 

 

 

General casualty (1)

$

480,142

 

$

343,170

Professional liability (2)

 

549,719

 

 

314,372

Financial lines (3)

 

259,104

 

 

144,386

Other (4)

 

310,491

 

 

233,695

Casualty and Specialty segment gross premiums written

$

1,599,456

 

$

1,035,623

(1)

Includes automobile liability, casualty clash, employer's liability, umbrella or excess casualty, workers' compensation and general liability.

(2)

Includes directors and officers, medical malpractice, and professional indemnity.

(3)

Includes financial guaranty, mortgage guaranty, political risk, surety and trade credit.

(4)

Includes accident and health, agriculture, aviation, cyber, energy, marine, satellite and terrorism. Lines of business such as regional multi-line and whole account may have characteristics of various other classes of business, and are allocated accordingly.

RenaissanceRe Holdings Ltd.

Supplemental Financial Data - Total Investment Result

(in thousands of United States Dollars, except percentages)

(Unaudited)

 

 

 

 

 

Three months ended

 

March 31,
2022

 

March 31,
2021

Fixed maturity investments trading

$

62,417

 

 

$

62,933

 

Short term investments

 

1,136

 

 

 

573

 

Equity investments trading

 

2,754

 

 

 

1,491

 

Other investments

 

 

 

Catastrophe bonds

 

17,360

 

 

 

14,468

 

Other

 

5,552

 

 

 

3,801

 

Cash and cash equivalents

 

(41

)

 

 

102

 

 

 

89,178

 

 

 

83,368

 

Investment expenses

 

(5,487

)

 

 

(3,564

)

Net investment income

 

83,691

 

 

 

79,804

 

 

 

 

 

Net realized and unrealized gains (losses) on:

 

 

 

Fixed maturity investments trading, net of investments-related derivatives (1)

 

(618,253

)

 

 

(261,759

)

Equity investments trading, net of investments-related derivatives (1)

 

(56,053

)

 

 

(67,922

)

Other investments

 

 

 

Catastrophe bonds

 

(8,261

)

 

 

(19,083

)

Other

 

9,550

 

 

 

3,201

 

Net realized and unrealized gains (losses) on investments

 

(673,017

)

 

 

(345,563

)

Total investment result

$

(589,326

)

 

$

(265,759

)

 

 

 

 

Total investment return - annualized

 

(10.2

) %

 

 

(4.9

) %

(1)

Net realized and unrealized gains (losses) on fixed maturity investments trading includes the impacts of interest rate futures, interest rate swaps, credit default swaps and total return swaps. Net realized and unrealized gains (losses) on equity investments trading includes the impact of equity futures.

Comments on Regulation G

In addition to the GAAP financial measures set forth in this Press Release, the Company has included certain non-GAAP financial measures within the meaning of Regulation G. The Company has provided these financial measures in previous investor communications and the Company's management believes that these measures are important to investors and other interested persons, and that investors and such other persons benefit from having a consistent basis for comparison between quarters and for comparison with other companies within the industry. These measures may not, however, be comparable to similarly titled measures used by companies outside of the insurance industry. Investors are cautioned not to place undue reliance on these non-GAAP measures in assessing the Company's overall financial performance.

Operating Income (Loss) Available (Attributable) to RenaissanceRe Common Shareholders and Operating Return on Average Common Equity - Annualized

The Company uses "operating Income (loss) available (attributable) to RenaissanceRe common shareholders" as a measure to evaluate the underlying fundamentals of its operations and believes it to be a useful measure of its corporate performance. "Operating Income (loss) available (attributable) to RenaissanceRe common shareholders" as used herein differs from "net income (loss) attributable to RenaissanceRe common shareholders," which the Company believes is the most directly comparable GAAP measure, by the exclusion of net realized and unrealized gains and losses on investments, excluding other investments - catastrophe bonds, net foreign exchange gains and losses, corporate expenses associated with the acquisition of TMR and the subsequent sale of RenaissanceRe (UK) Limited ("RenaissanceRe UK"), the income tax expense or benefit associated with these adjustments and the portion of these adjustments attributable to the Company's redeemable noncontrolling interests. The Company's management believes that "operating Income (loss) available (attributable) to RenaissanceRe common shareholders" is useful to investors because it more accurately measures and predicts the Company's results of operations by removing the variability arising from: fluctuations in the fair value of the Company's fixed maturity investment portfolio, equity investments trading, other investments (excluding catastrophe bonds) and investments-related derivatives; fluctuations in foreign exchange rates; corporate expenses associated with the acquisition of TMR and the subsequent sale of RenaissanceRe UK; the associated income tax expense or benefit of these adjustments; and the portion of these adjustments attributable to the Company's redeemable noncontrolling interests. The Company also uses "operating Income (loss) available (attributable) to RenaissanceRe common shareholders" to calculate "operating Income (loss) available (attributable) to RenaissanceRe common shareholders per common share - diluted" and "operating return on average common equity - annualized." The following table is a reconciliation of: (1) net income (loss) attributable to RenaissanceRe common shareholders to "operating Income (loss) available (attributable) to RenaissanceRe common shareholders"; (2) net income (loss) attributable to RenaissanceRe common shareholders per common share - diluted to "operating Income (loss) available (attributable) to RenaissanceRe common shareholders per common share - diluted"; and (3) return on average common equity - annualized to "operating return on average common equity - annualized." Comparative information for all prior periods has been updated to conform to the current methodology and presentation.

 

Three months ended

(in thousands of United States Dollars, except per share amounts and percentages)

March 31,
2022

 

March 31,
2021

Net income (loss) available (attributable) to RenaissanceRe common shareholders

$

(394,413

)

 

$

(290,934

)

Adjustment for net realized and unrealized losses (gains) on investments, excluding other investments - catastrophe bonds

 

664,756

 

 

 

326,480

 

Adjustment for net foreign exchange losses (gains)

 

15,486

 

 

 

22,788

 

Adjustment for corporate expenses associated with the acquisition of TMR and the subsequent sale of RenaissanceRe UK

 

?

 

 

 

135

 

Adjustment for income tax expense (benefit) (1)

 

(41,874

)

 

 

(19,965

)

Adjustment for net income (loss) attributable to redeemable noncontrolling interests (2)

 

(92,010

)

 

 

(34,109

)

Operating income (loss) available (attributable) to RenaissanceRe common shareholders

$

151,945

 

 

$

4,395

 

 

 

 

 

Net income (loss) available (attributable) to RenaissanceRe common shareholders per common share - diluted

$

(9.10

)

 

$

(5.87

)

Adjustment for net realized and unrealized losses (gains) on investments, excluding other investments - catastrophe bonds

 

15.33

 

 

 

6.59

 

Adjustment for net foreign exchange losses (gains)

 

0.36

 

 

 

0.46

 

Adjustment for corporate expenses associated with the acquisition of TMR and the subsequent sale of RenaissanceRe UK

 

?

 

 

 

?

 

Adjustment for income tax expense (benefit) (1)

 

(0.97

)

 

 

(0.40

)

Adjustment for net income (loss) attributable to redeemable noncontrolling interests (2)

 

(2.12

)

 

 

(0.69

)

Operating income (loss) available (attributable) to RenaissanceRe common shareholders per common share - diluted

$

3.50

 

 

$

0.09

 

 

 

 

 

Return on average common equity - annualized

 

(28.1

) %

 

 

(17.1

) %

Adjustment for net realized and unrealized losses (gains) on investments, excluding other investments - catastrophe bonds

 

47.3

%

 

 

19.2

%

Adjustment for net foreign exchange losses (gains)

 

1.1

%

 

 

1.4

%

Adjustment for corporate expenses associated with the acquisition of TMR and the subsequent sale of RenaissanceRe UK

 

?

%

 

 

?

%

Adjustment for income tax expense (benefit) (1)

 

(3.0

) %

 

 

(1.2

) %

Adjustment for net income (loss) attributable to redeemable noncontrolling interests (2)

 

(6.5

) %

 

 

(2.0

) %

Operating return on average common equity - annualized

 

10.8

%

 

 

0.3

%

(1)

Represents the income tax (expense) benefit associated with the adjustments to net income (loss) available (attributable) to RenaissanceRe common shareholders. The income tax impact is estimated by applying the statutory rates of applicable jurisdictions, after consideration of other relevant factors.

(2)

Represents the portion of these adjustments that are attributable to the Company's redeemable noncontrolling interests, including the income tax impact of those adjustments.

Tangible Book Value Per Common Share and Tangible Book Value Per Common Share Plus Accumulated Dividends

The Company has included in this Press Release "tangible book value per common share" and "tangible book value per common share plus accumulated dividends." "Tangible book value per common share" is defined as book value per common share excluding goodwill and intangible assets per share. "Tangible book value per common share plus accumulated dividends" is defined as book value per common share excluding goodwill and intangible assets per share, plus accumulated dividends. The Company's management believes "tangible book value per common share" and "tangible book value per common share plus accumulated dividends" are useful to investors because they provide a more accurate measure of the realizable value of shareholder returns, excluding the impact of goodwill and intangible assets. The following table is a reconciliation of book value per common share to "tangible book value per common share" and "tangible book value per common share plus accumulated dividends."

 

March 31,
2022

 

December 31,
2021

 

September 30,
2021

 

June 30,
2021

 

March 31,
2021

Book value per common share

$

121.44

 

 

$

132.17

 

 

$

128.91

 

 

$

139.35

 

 

$

131.15

 

Adjustment for goodwill and other intangibles (1)

 

(5.89

)

 

 

(5.90

)

 

 

(5.67

)

 

 

(5.60

)

 

 

(5.42

)

Tangible book value per common share

 

115.55

 

 

 

126.27

 

 

 

123.24

 

 

 

133.75

 

 

 

125.73

 

Adjustment for accumulated dividends

 

23.89

 

 

 

23.52

 

 

 

23.16

 

 

 

22.80

 

 

 

22.44

 

Tangible book value per common share plus accumulated dividends

$

139.44

 

 

$

149.79

 

 

$

146.40

 

 

$

156.55

 

 

$

148.17

 

 

 

 

 

 

 

 

 

 

 

Quarterly change in book value per common share

 

(8.1

) %

 

 

2.5

%

 

 

(7.5

) %

 

 

6.3

%

 

 

(5.3

) %

Quarterly change in tangible book value per common share plus change in accumulated dividends

 

(8.2

) %

 

 

2.8

%

 

 

(7.6

) %

 

 

6.7

%

 

 

(5.3

) %

Year to date change in book value per common share

 

(8.1

) %

 

 

(4.5

) %

 

 

(6.9

) %

 

 

0.6

%

 

 

(5.3

) %

Year to date change in tangible book value per common share plus change in accumulated dividends

 

(8.2

) %

 

 

(4.0

) %

 

 

(6.6

) %

 

 

1.0

%

 

 

(5.3

) %

(1)

At March 31, 2022, December 31, 2021, September 30, 2021, June 30, 2021, and March 31, 2021, goodwill and other intangibles included $18.4 million, $18.6 million, $19.0 million, $22.4 million, and $22.7 million, respectively, of goodwill and other intangibles included in investments in other ventures, under equity method.

 


These press releases may also interest you

19 avr 2024
Voxtur Analytics Corp. , a North American technology company creating a more transparent and accessible real estate lending ecosystem, is pleased to announce that it has engaged the services of ICP Securities Inc. ("ICP") to provide automated market...

19 avr 2024
On April 19, 2024, the board of directors of Portland General Electric Company declared a quarterly common stock dividend of $0.50 per share, representing an increase of 5.3%, or $0.10 per share, on an annualized basis. The company's dividend is...

19 avr 2024
Adyton Resources Corporation  ("Adyton" or the "Company") announces it has closed its previously announced non-brokered private placement offering, pursuant to which it has issued 50,000,000 common shares of the Company ("Shares") at a price of...

19 avr 2024
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...

19 avr 2024
Lion Group Holding Ltd. ("Lion" or "the Company") , the operator of an all-in-one trading platform that offers a wide spectrum of products and services, today announced that on April 18, 2024, it received a delinquency notification letter from the...

19 avr 2024
Cosmos Health Inc. ("Cosmos Health" or the "Company'') , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor...



News published on and distributed by: